November 3, 2026
Regional intelligence on Drugs, Diagnostics, Devices & Digital Health
* may need subscription to view
Big4Bio CEO Weekly - Q&A Life Sciences Leaders
BIG4BIO CEO WEEKLY Q&A:
Lewis H. Bender, Founder & CEO, Intensity Therapeutics
In this Q&A, Bender discusses the insight behind Intensity's approach, what sets its delivery platform apart, lessons he's learned leading a biotech company through an IPO and late-stage trials, and changes needed to get more effective, less toxic treatments to patients faster. More

Press Releases

  • Accutar: Achievement of Preclinical Development Milestone in Research Collaboration With Evommune on TLR7/8 Program More
  • Alfasigma: New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026 More
  • Merck: Initiates Phase 3 Study Evaluating Ohtuvayre (ensifentrine) for the Prevention of COPD Exacerbations in Adult Patients Receiving Standard of Care With a History of Exacerbations More
  • Phathom Pharmaceuticals: Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA (vonoprazan) Tablets Exclusively at BlinkRx More
  • SK Life Science: Introduces Access+ to Simplify the Patient Support Experience More
  • Teva: Will Discontinue Phase 2 TOPAS-MSA Study of Emrusolmin (TEV-‘286) Following Interim Futility Analysis More More More*

Financial News

  • Amneal: Third Quarter 2026 Financial Results More
  • Biopharma Therapeutics and Platforms R&D Partnerships – Q3 2026 Review More
  • Compass Pathways: Third Quarter 2026 Financial Results and Business Highlights More
  • Dianthus Therapeutics: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
  • Henry Schein: Strong 2026 Third Quarter and Raises FY2026 Guidance More
  • Merck: Recommends Rejection of Tutanota’s “Mini-Tender” Offer More
  • More on FDA Putting Bright Minds Drug on Partial Hold, Stock Tanking More* More* More
  • More on Regeneron Third-Quarter Revenue Jumping 36% as Sanofi Collaboration and Eylea HD Drive Beat More* More
  • Pfizer: Strong Third-Quarter 2026 Results and Raises 2026 Guidance More
  • Syndax: Third Quarter 2026 Financial Results and Business Update More
Cardinal Health Logo
Turn unstructured bladder cancer data into actionable real-world insights
Download the case study to learn how.

Media/Misc Coverage

  • Big4Bio CEO Weekly Q&A: Lewis H. Bender, Founder & CEO, Intensity Therapeutics More
  • Biotech & Pharma Updates | November 2, 2026 More
  • More on Compass Pointing to Unmet Need in Depression as Landmark Psychedelic Nears Market More
  • More on FDA Approving Sun Pharma’s Ilumya for Psoriatic Arthritis, as Clinic-Administered Il-23 Inhibitor More* More*
  • Subscribe to LifeSci Startup for Updates on US Startups More

Career Moves

Slone Partners Places Farhad Ghavami as Chief Executive Officer at SeqCenter
Learn More  →
  • Anavex Life Sciences: Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors More
  • CollectiveMinds: The Boardroom Is Changing. Is Your Experience Visible? More
  • OPPORTUNITY: Director of Compliance, Remote More
  • OPPORTUNITY: Head of Market Development & Strategy, California More
  • OPPORTUNITY: Senior Vice President, Regulatory Affairs & Quality Assurance, Boston More
  • Pfizer: Appoints Cecile Guegan as Chief Financial Officer More
  • Slone Partners: Doing More With Less - Building the Right Nonprofit Leadership Team in a Resource-Constrained Environment More
  • Slone Partners: Leading Through AI - The New Playbook for Healthtech Executives More
  • Syndax: CFO Transition – Aaron A. Ondrey Appointed Chief Financial Officer More
  • U.S. Bioscience Jobs Up 7% From 2021 to 2025: Report More
On Your Mark 2027 | Every event of JPM Week. Jnauary 11-14, San Francisco. List your event - free. onyourmark.bio

Events

Note: Events may be in any Big4Bio region or virtual
Spotlight Event: Biotech Showcase, Jan 11-13
Learn More  →
  • Aggression in Mice: Bridging Evidence, Best Practices, and Scientific Rigor Nov 4
  • Scaling Academic Research Programs Through Strategic Colony Management Partnerships Nov 11
  • 23rd Annual Pantheon Awards Nov 12
  • 2026 LSPA Patient Summit Nov 12
  • Patient Pathways (Use code 26B4B10 for 10% off) Nov 17-20
  • Pricing & Contracting WEST (Use code 26B4B10 for 10% off) Dec 7-8
  • Trade and Channel Strategies (Use code 26B4B10 for 10% off) Dec 8-10
  • Advancing Drug Development Forum Dec 10

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES
Big4Bio: NYC Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory Provided courtesy of
BioPharmGuy Logo

NYC Sponsors


Follow us


Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:NYC, all rights reserved 2026

© 2026 Big4Bio, a division of BigBio Communications. All rights reserved.